NannyML develops enterprise software to monitor machine learning models in production, enabling decision-makers to understand how AI decisions evolve and how changes affect business outcomes. The platform detects data drift and concept drift, estimates potential model degradation, and provides actionable insights through a dashboard that communicates model decisions to both business and technical stakeholders. It focuses on bridging the gap between business use and AI, helping organizations keep ML systems reliable, maintain value, and act on insights. The company was founded in 2020 and is based in Leuven, Belgium.
NannyML
Venture Round in 2025
NannyML develops enterprise software to monitor machine learning models in production, enabling decision-makers to understand how AI decisions evolve and how changes affect business outcomes. The platform detects data drift and concept drift, estimates potential model degradation, and provides actionable insights through a dashboard that communicates model decisions to both business and technical stakeholders. It focuses on bridging the gap between business use and AI, helping organizations keep ML systems reliable, maintain value, and act on insights. The company was founded in 2020 and is based in Leuven, Belgium.
Bio-Sourcing
Venture Round in 2024
BioSourcing is a biotechnology company based in Liège, Belgium, focused on developing a new generation of biotherapeutics, particularly monoclonal antibodies, to address global unmet medical needs. The company employs advanced technologies, including genome editing techniques like CRISPR, to innovate the design of biotherapeutics. This disruptive approach significantly reduces capital requirements and production costs, especially for large-scale manufacturing, while enhancing the quality and efficiency of biopharmaceuticals through improved glycosylation processes. BioSourcing is committed to sustainability, aiming to minimize the carbon footprint associated with biotherapeutic production. The company boasts a team of leading scientists and international experts, supported by strategic partnerships with key players in the pharmaceutical and biotechnology sectors.
Bio-Sourcing
Grant in 2024
BioSourcing is a biotechnology company based in Liège, Belgium, focused on developing a new generation of biotherapeutics, particularly monoclonal antibodies, to address global unmet medical needs. The company employs advanced technologies, including genome editing techniques like CRISPR, to innovate the design of biotherapeutics. This disruptive approach significantly reduces capital requirements and production costs, especially for large-scale manufacturing, while enhancing the quality and efficiency of biopharmaceuticals through improved glycosylation processes. BioSourcing is committed to sustainability, aiming to minimize the carbon footprint associated with biotherapeutic production. The company boasts a team of leading scientists and international experts, supported by strategic partnerships with key players in the pharmaceutical and biotechnology sectors.
Pharrowtech specializes in designing advanced solutions for fixed-wireless access, wireless VR/AR, and ultra-high capacity wireless links. With over a decade of top-tier R&D experience from imec, Belgium's renowned research hub, the company focuses on algorithm, chip, and antenna design for millimeter-wave systems to deliver products with superior performance, power efficiency, and cost-effectiveness.
Pharrowtech
Venture Round in 2024
Pharrowtech specializes in designing advanced solutions for fixed-wireless access, wireless VR/AR, and ultra-high capacity wireless links. With over a decade of top-tier R&D experience from imec, Belgium's renowned research hub, the company focuses on algorithm, chip, and antenna design for millimeter-wave systems to deliver products with superior performance, power efficiency, and cost-effectiveness.